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Abstract. Hydrogen peroxide (H2O2) is an important signaling molecule in cancer cells. 
However, the significant secretion of H2O2 by cancer cells have been rarely observed. Cold 
atmospheric plasma (CAP) is a near room temperature ionized gas composed of neutral particles, 
charged particles, reactive species, and electrons. Here, we first demonstrated that breast cancer 
cells and pancreatic adenocarcinoma cells generated micromolar level H2O2 during just 1 min of 
direct CAP treatment on these cells. The cell-based H2O2 generation is affected by the medium 
volume, the cell confluence, as well as the discharge voltage. The application of cold 
atmospheric plasma (CAP) in the cancer treatment has been intensively investigated over the 
past decade. Several cellular responses to the CAP treatment have been observed including the 
consumption of the CAP-originated reactive species, the rise of intracellular reactive oxygen 
species, the damage on DNA and mitochondria, as well as the activation of apoptotic events. 
This is a new previously unknown cellular response to CAP, which provides a new prospective 
to understand the interaction between CAP and cells.  
 
Keywords. Cold atmospheric plasma; cancer cells; cell-based H2O2 generation; plasma 
medicine.  
 
Introduction.   
H2O2 is an important signaling molecule in cancer cells (1). The production of nanomolar (nM) 
level of H2O2 by several cancer cell lines including melanomas, neuroblastoma, colon carcinoma, 
and ovarian carcinoma have been observed two decades ago (2). H2O2 may increase the genetic 
instability of cancer cells by inducing DNA strand breaks, damage on guanine or thymine bases, 
and the sister chromatid exchanges, which may facilitate the malignant process of cancer cells, 
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such as proliferation, apoptosis resistance, metastasis, angiogenesis and hypoxia-inducible factor 
1 activation (1, 2). On the other hand, H2O2 alone with a relative high concentration or as the 
mediator of a series of anticancer drugs can selectively induce apoptosis in cancer cells (1, 3–5). 
H2O2 may have promising application in cancer treatment at least as a mediator of series of 
physical or chemical strategies.  
 
Cold atmospheric plasma (CAP), a near room temperature ionized gas composed of charged 
particles, neutral particles and electrons, has shown its promising application in cancer treatment 
over the past decade (6–11). CAP not only effectively decreases the growth of many cancer cell 
lines in vitro through reactive species-triggered cell death but also significantly inhibits or halts 
the growth of subcutaneous xenograft tumors or melanoma in mice by the direct CAP treatment 
just above the skin (8, 14–17). The reactive oxygen species (ROS) and the reactive nitrogen 
species (RNS) have been regarded as the main factors contributing to the complicate interaction 
between CAP and cancer cells in vitro and in vivo (12, 13). Many studies conclude that the death 
of the CAP-treated cancer cells in vitro is due to the apoptosis triggered by the significant rise of 
intracellular ROS, DNA damage, as well as mitochondrial damage (7, 11, 18–21).  
 
Among dozens of CAP-originated species in aqueous solutions, H2O2 has been proven to be a 
main factor triggering the death of cancer cells in vitro (22–26). H2O2 has not been detected in 
the emission spectra of CAP in the gas phase (19). The H2O2 in aqueous solution is due to the 
recombination reactions between short-life species OH. (27, 28). To date, CAP is the only 
confirmed extracellular H2O2 source in plasma medicine. Cells have just been regarded as a 
consumer for the H2O2 generated by CAP (11, 24).
 However, using a solution with H2O2 alone 
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does not cause the same decrease in cancer cells viability as seen following the CAP treatment 
(29, 30). Thus, the CAP treatment on cancer cells cannot be simply regarded as a 
H2O2-treatment.  
 
In addition to the direct CAP treatment, another strategy using the CAP-stimulated solutions 
(PSS) to inhibit the growth of cancer cells in vitro or to inhibit the growth of tumorous tissues in 
mice through injection has been also demonstrated recently (31–34). PSS is also named as the 
indirect CAP treatment or the CAP-activated solutions (24, 35). For the direct CAP treatment in 
vitro, a thin layer of cell culture medium is used to cover cancer cells (36). This medium layer 
facilitates the transition of the reactive species in the gas phase of CAP into the dissolved 
reactive species in medium (36). The direct CAP treatment can be regarded essentially the same 
as the indirect CAP treatment if we assume that the finally formed long-life reactive species such 
as H2O2, NO2
-, ONOO- in the CAP-treated solution is the sole factor leading to decreased tumor 
cell viability. However, considering the potential interaction between the short-life species such 
as superoxide (O2
-), hydroxyl radicals (OH.) in CAP and cells, the direct CAP treatment should 
be different from the indirect CAP treatment. PSS will not contain short-life species. So far, no 
direct experimental evidence has been found to describe such essential difference.  
 
In this study, we first provide the experimental evidence that the 1 min of CAP treatment can 
trigger μM level cancer cells-based H2O2 generation through comparing the H2O2 generation in 
the CAP-treated cell-free medium and the CAP-treated cancer cells covered by a thin layer of 
medium. Such cells-based H2O2 generation can be regulated by controlling the volume of the 
medium layer, the cell confluence and the discharge voltage. This study provides the first 
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evidence that cells can not only quickly consume H2O2 but also significantly generate H2O2 
through CAP treatment. This is a novel perspective to understand the interaction between CAP 
and cells.  
 
Experiments and Results.  
Consuming the extracellular H2O2 is a basic response of cancer cells cultured in the 
H2O2-containing environment (11, 24). We have demonstrated that the CAP-originated H2O2 
could be completely consumed just several hours after using the CAP-stimulated DMEM to 
culture glioblastoma (U87MG) cells (11). In this study, we investigated the evolution of 
extracellular H2O2 in PSM and H2O2-DMEM, which have been used to culture cancer cell lines. 
All solutions contained 36.3 μM H2O2. The H2O2 concentration in PSM and H2O2-DMEM 
decreases as the culture time increases (Fig. S1). At a higher cell confluence, a faster H2O2 
consumption rate is noted. To date, all three cancer cell lines we studied have shown a similar 
feature that cancer cells quickly consume the extracellular H2O2 in just 3 hr. This observation is 
consistent with the observation that the rise of intracellular ROS started immediately after the 
CAP treatment and ended just about 3 hr post the CAP treatment (37).  
 
To date, the direct CAP treatment is the main strategy to investigate the toxicity of CAP on 
cancer cells in vitro (8, 31, 32). In this study, we measured the H2O2 concentration in a thin layer 
of DMEM which has been used to immerse cells during the direct CAP treatment. Without the 
protection of such medium layer, cancer cells are killed immediately due to the dehydration 
caused by the helium flow from the CAP jet tube. Based on the preliminary test, 20 μL per well 
on a 96-wells plate was the minimum volume to preclude the impact of helium flow (Fig. S2). In 
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addition, the volume effect of this thin DMEM layer was also investigated through increasing the 
volume from 20 μL to 100 μL. Three general trends have been observed when we immediately 
measured the H2O2 concentration in DMEM after the treatment. First, the concentration of H2O2 
in all cases increases as the volume of DMEM decreases (Fig. 1A). This result may be due to the 
principle that a salute will form in a larger concentration when the volume of solvent (reactive 
species) is smaller. Second, the direct CAP treatment on pancreatic adenocarcinoma cells 
(PA-TU-8988T) and breast adenocarcinoma cells (MDA-MB-231) rather than on glioblastoma 
cells (U87MG) generates significantly more H2O2 than the same CAP treatment on DMEM in 
the same volume (Fig. 1A). This trend is more obvious when the volume of DMEM is smaller. 
U87MG cells will show similar feature only at some specific conditions such as at a medium 
volume of 80 μL and 100 μL. The generation of H2O2 is also illustrated as the change in H2O2 
concentration between the CAP-treated DMEM with and without cells (Fig. 1B). The volume of 
DMEM is also a key factor to affect the cells-based H2O2 generation. The maximum relative 
H2O2 generation from MDA-MB-231 cells, PA-TU-8988 cells, and U87MG occurs when the 
volume of DMEM is 50 μL, 100 μL, and 80 μL, respectively (Fig. 1B). More importantly, only 
the direct CAP treatment on cancer cells can cause such cells-based H2O2 generation. The 
CAP-stimulated DMEM cannot generate the similar response on all three cell lines (Fig. 1C). 
The response of cancer cells to PSM is just consuming H2O2, as seen in Fig. S1. In addition, all 
three cell lines do not generate H2O2 without the CAP treatment.  
 
To investigate whether the CAP-treated cancer cells will continue to generate H2O2 post the CAP 
treatment, the change of H2O2 concentration in DMEM after the direct CAP treatment on cancer 
cells and the CAP-treated DMEM has been studied. For all cell lines, the H2O2 concentration in 
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DMEM gradually decreases post the CAP treatment (Fig. 2). Such a decay trend has not been 
observed during the evolution of the CAP-treated DMEM. Thus, the decreased H2O2 
concentration is due to the consumption of cancer cells on the extracellular H2O2. The 
cells-based H2O2 generation occurs only when the direct CAP treatment is performed. Once the 
CAP treatment ceases, the generation of H2O2 stops. When the H2O2 concentration measurement 
was performed at the tenth min after the CAP treatment, the cells-based H2O2 generation was no 
longer observed (Fig. 2). This may explain why the cells-based H2O2 generation has not been 
observed in the previous studies.  
 
In addition to the volume of DMEM used to cover cancer cells during the CAP treatment, the 
cell confluence and the discharge voltage can also affect the cells-based H2O2 generation. Under 
the same experimental conditions, the maximum of the cells-based H2O2 generation of 
MDA-MB-231 cells, and PA-TU-8988T cells appears when the cell confluence is 1 x 104 
cells/mL and 3 x 104 cells/mL, respectively (Fig. 3A). For U87MG cells, the significant effect of 
the cell confluence on the cells-based H2O2 generation was not observed (Fig. 3A). The 
discharge voltage is an important physical factor during the CAP treatment. The change of 
discharge voltage in a short range can significantly change the chemical composition of CAP. 
According to prior research, the increase of output (discharge) AC voltage from 2.56 kV to 3.80 
kV will significantly increase the generation of the nitrogen-based species such as N2
+ and 
NO/N2 in the gas phase of CAP (38). The generation of the oxygen-based species such as O and 
OH. just slightly increases during the same process (38). Thus, the ratio between the 
oxygen-based species and the nitrogen-based species decreases as the output voltage increases. 
We observed the same trend in the CAP-stimulated PBS that the concentration ratio between 
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H2O2 and NO2
- decreases from 11.2 to 5.5 as the output voltage increases from 3.02 kV to 3.85 
kV. In this study, the increase of the output voltage significantly weakens the cells-based H2O2 
generation (Fig. 3B). A large output voltage will completely inhibit the cells-based H2O2 
generation for all three cell lines.  
 
H2O2 has been regarded as a main anti-cancer reactive species in the CAP treatment in vitro (24–
26). Because the observation that the direct CAP treatment on cancer cells immersed in a thin 
layer of DMEM causes a significantly stronger H2O2 generation than that seen with the indirect 
CAP treatment on DMEM, it is reasonable to speculate that the direct CAP treatment will cause 
a stronger anti-cancer effect on cancer cells than the indirect CAP treatment does under the same 
experimental conditions. Such a comparison was performed on MDA-MB-231 cells and 
PA-TU-8988T cells. As shown in Fig. 4A and 4B, both cell lines are much more vulnerable to 
the direct CAP treatment than the indirect CAP treatment. In addition, it was further 
demonstrated that the strong anti-cancer effect of the direct CAP treatment on the two cell lines 
could nearly be completely counteracted by pre-treating cancer cells with 6 mM intracellular 
ROS scavenger NAC or by removing the DMEM immersing cancer cells and replacing it with 
new untreated DMEM immediately after the direct CAP treatment (Fig. 5C and 5D). Thus, the 
anti-cancer effect of the direct CAP treatment on cancer cells is still based on a rise of 
intracellular ROS due to the extracellular reactive species dissolved in DMEM. Moreover, the 
volume of DMEM does not show a noticeable impact on the anti-cancer effect of the direct or 
the indirect CAP treatment, though corresponding H2O2 concentration in DMEM varies 
drastically with the volume (Fig. 1). This difference indicates that other factors such as the whole 
reactive species amount rather than the concentration of reactive species may dominate the 
anti-cancer effect. In addition to the general trend introduced above, a slight difference on the 
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anti-cancer effect due to the volume of DMEM still can be observed on MDA-MB-231 cells. The 
strongest anti-cancer effect of the direct CAP treatment on MDA-MB-231 cells occurs when the 
volume of DMEM is 50 μL.  
 
Discussion.  
Since the first observation that the CAP treatment could cause apoptosis in lung cancer cells line 
in 2004 and the first complete study on the anti-cancer effect of dielectric barrier discharge 
(DBD) on melanoma cells in 2007, the research on the application of CAP in the cancer 
treatment experienced an exponential development (7, 8, 11). While understanding the 
anti-cancer mechanism at the molecular and cellular level is far from clear, it is widely 
acknowledged that the CAP-originated reactive species are the main anti-cancer factors 
inhibiting the growth of cancer cells in vitro (6–8, 10, 11). However, in all previous studies, the 
cancer cells have just been regarded as having a passive role in plasma medicine to sustain the 
attack from the reactive species such as H2O2 (6–8, 10, 11). This study first demonstrates that 
specific cancer cells such as pancreatic adenocarcinoma cells and breast adenocarcinoma cells 
will generate significant amount of H2O2 as a response to the direct CAP treatment. For example, 
MDA-MB-231 cells generate about 85% more H2O2 than the CAP treatment does when the 
volume of DMEM was 50 μL. Despite only three cell lines has shown such cells-based H2O2 
generation capacity in this study, such cellular response may be commonly existed in other 
cancer cell lines which has not been studied. And, it is completely possible that such feature may 
also be owned by other cells including normal mammalian cells, bacteria, as well as yeasts. 
These cells have been investigated in plasma medicine for decades (37, 39, 40).  
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We hypothesize that the short-life species in CAP may stimulate the H2O2 production by cancer 
cells. First, the H2O2 generation by cancer cells occurs only during the CAP treatment. The 
cessation of CAP treatment will immediately cause the consumption of H2O2 to be the dominate 
response of cancer cells (Fig. 2). Consuming H2O2 is a basic response of cancer cells in an 
H2O2-containing environment (Fig. S1). It is possible that H2O2 consumption capacity and the 
H2O2 generation capacity coexist during the CAP treatment. U87MG cells show a much stronger 
H2O2 consumption capacity compared with breast cancer cell lines (11, 24). Thus, the weak 
cell-based H2O2 generation by U87MG cells may be due to its strong H2O2 consumption capacity 
which dominates the interaction between U87MG cells and CAP.  
 
The short-life species in CAP has been regarded as a main source to form H2O2 in the 
CAP-stimulated solutions, though the corresponding mechanism is still disputable (41, 42). Such 
H2O2 formation is an aqueous solution-based reaction. Hydroxyl radicals may form H2O2 by a 
simple reaction: OH. + OH. → H2O2 (27, 28). H2O2 may also be formed by the recombination 
reaction based on hydroperoxyl radicals (HO2): HO2 + HO2 → H2O2 + O2 (27). HO2 may be 
formed by a reaction involving O2
-: O2
- + H+ → HO2 (27). For the cells-based H2O2 generation, 
H2O2 may be formed by a dismutation reaction catalyzed by the extracellular superoxide 
dismutase (Ex-SOD, SOD3) on the cytoplasmic membrane of cancer cells (22, 23). Superoxide 
is provided by CAP (39). The expression of SOD3 have been found in human pancreatic 
adenocarcinoma tissues, estrogen-induced breast cancer tissues, and breast carcinoma cell 
(MCF-7, MDA-MB-231), but not in glioblastoma cells, which may explain why cell-based H2O2 
production has not been noticeably observed in the CAP-treated U87MG cells (43–45).  
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The discovery of cell-based H2O2 generation provides a new feature which distinguishes the 
CAP treatment and simple chemical treatment such as the H2O2 treatment. The direct CAP 
treatment causes a much stronger anti-cancer effect on pancreatic adenocarcinoma cells and 
breast adenocarcinoma cells than the indirect CAP treatment does (Fig. 4). Such difference may 
be at least partially due to the cells-based H2O2 generation during the CAP treatment (Fig. 1). 
Nonetheless, it is necessary to emphasize that the weak anti-cancer capacity of the indirect CAP 
treatment (PSS) revealed in this study is mainly due to the small diameter of the wells in 
96-wells plate. As we demonstrated in previous study, the diameter of multi-wells plate is 
proportional to the reactive species concentration and the anti-cancer effect of PSS (24). 
Consequently, the PSS made in 6-wells plate will be much more toxic to cancer cells than the 
PSS made in 96-wells plate (24). 
 
More importantly, this study provides a new perspective to understand the potential cellular 
interaction during the CAP treatment, which also provide clues to understand the anti-cancer 
capacity of CAP in vivo. In addition to the proven selective anti-cancer capacity of CAP in vitro 
to cancer cells, another attractive feature of CAP is its promising anti-cancer effect seen in vivo. 
A series of investigations have achieved a similar conclusion that the growth of subcutaneous 
xenograft tumors or melanoma in mice can be significantly halted by the CAP treatment just 
above the skins of mice or on the exposed cancerous tissues in mice (15–17, 46). The mechanism 
governing these descriptions is nearly completely unknown. ROS and RNS may also be the main 
factors contributing to the decreased tumor cell viability in vivo by the CAP treatment through 
directly attacking tumor or indirectly activating the immune response in vivo to further kill tumor 
cells (18, 47, 48). The trans-skin motion (diffusion, transportation or other physical ways) of 
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reactive species may be a key to understand the anti-cancer capacity in vivo. Several attempts 
have been performed to understand such processes. The diffusion of reactive species across the 
skin analogue has been observed (49, 50). Our study provides a novel explanation for the 
trans-skin motion of reactive species. The short-life reactive species, may activate cells to 
generate long-life reactive species such as H2O2 through the similar ways revealed in this study. 
The tumor tissue may be immersed in a H2O2-rich environment even the CAP treatment does not 
directly generate a significant amount of H2O2 on the relative dry skin. The cells in the skin and 
the cells in the tumor may have similar mutual interaction through generating toxic chemicals 
such as H2O2 to neighbor cells. H2O2 is a second messenger in the lymphocyte activation (51, 52). 
μM level of H2O2 rapidly induced the activation of the transcription factor NF-κB and early gene 
expression of interleukin-2 (IL-2) and the IL-2 receptor α chain (51). The H2O2-generating tumor 
tissues may be a potential target for the immune system. The anti-cancer capacity of the CAP 
treatment in vivo may involve the H2O2-activated immune attack on tumor tissues.  
 
Conclusions.  
A new previously unknown basic cellular response to the CAP treatment is demonstrated in this 
study. Only direct CAP treatment on breast adenocarcinoma cells and pancreatic 
adenocarcinoma cells immersed in a thin layer of medium results in μM level of cell-based H2O2 
generation. The measured maximum H2O2 generation based on CAP-stimulated MDA-MB-231 
cells immersed in a thin layer of DMEM is about 85% more than that formed in the 
CAP-stimulated same medium but lacking cells. Controlling the volume of medium, the cell 
confluence, and the plasma discharge voltage can regulate the cell-based H2O2 generation. The 
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abundant short-life reactive species in CAP may trigger this unique cellular response, which 
gives a new perspective to understand the interaction between CAP and cells in vitro and in vivo.  
 
Methods.  
CAP device. The CAP device used in this study was a typical CAP jet generator using helium as 
the carrying gas. The noticeable anti-cancer effect of this device has been demonstrated through 
a series of previous investigations from our lab (24, 53). The detailed introduction for this device 
was illustrated in previous reports (24, 53). Here, a short introduction is given. A violet plasma 
jet was generated between a central anode and a ring grounded cathode. The discharge was 
driven by an alternating current high voltage (3.16 kV) with a frequency of 30 kHz. The 
generated CAP was ejected out from a quartz tube with a diameter of 4.5 mm. The flow rate of 
helium was about 4.7 L/min. The input voltage of DC power was 11.5 V. According to the 
emission spectrum, the CAP in the gas phase was mainly composed of ROS (OH., O), RNS (NO, 
N2
+), and helium (He) (38).  
 
Cell cultures. Human pancreas adenocarcinoma cells (PA-TU-8988T) and human glioblastoma 
cells (U87MG) were provided by Dr. Murad’s lab at the George Washington University. Human 
breast adenocarcinoma cells (MDA-MB-231) were provided by Dr. Zhang’s lab at the George 
Washington University, and cultured in the same protocol as previous studies. The Dulbecco’s 
modified Eagle’s medium (DMEM) was purchased from Life Technologies (11965-118). 
DMEM was mixed with 1% (v/v) penicillin and streptomycin solution (Life Technologies, 
15140122). The medium used in the cell culture and seeding was composed of DMEM 
supplemented with 10% (v/v) fetal bovine serum (ThermoFisher Scientific, 26140079) and 1% 
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(v/v) penicillin and streptomycin solution (Life Technologies, 15140122). In each experiment, 
100 μL of cancer cells harvesting solutions were seeded in a well on a 96-wells plate (Corning, 
62406-081) a day prior to the CAP treatment. These cancer cells were cultured 24 hr under the 
standard cell culture conditions (a humidified, 37°C, 5% CO2 environment). All wells on the 
margins of 96-wells plate were not used.  
 
Making (N-Acetyl-L-cysteine) NAC-DMEM and pre-treating cancer cells. 6 mM 
NAC-DMEM was made by dissolving NAC powder (A7250, Sigma-Aldrich) in DMEM. The 
whole medium which has been used to culture cancer cells overnight were removed first. Then, 
100 μL of NAC-rich DMEM was used to culture cancer cells in the well of a 96-wells plate. 
After 3 hr, 6 mM NAC-DMEM was removed before the further treatment.  
 
The direct and the indirect CAP treatment on cancer cells. The gap between the bottom of 
12-wells plate and the CAP source was set to be 3 cm. All DMEM used in the CAP treatment 
was made of mixing 1% (v/v) penicillin-streptomycin solution (Life Technologies, 15140122) 
with standard DMEM (Life Technologies, 11965-118). The schematically illustration of the 
protocols was presented in Fig. S4. Prior to the direct CAP treatment, the medium which has 
been used to culture cells overnight was removed. After this step, for the direct CAP treatment, 
the DMEM with a specific volume such as 20 μL was transferred to cover the cancer cells in a 
well on a 96-wells plate. After that, the CAP jet was used to vertically treat the cancer cells for 1 
min. For the indirect CAP treatment, the CAP-stimulated DMEM (PSM) was used to affect the 
growth of cancer cells cultured in a 96-wells plate. To make PSM, the DMEM with a specific 
volume such as 30 μL in a well on a 96-wells plate was treated by CAP jet vertically for 1 min. 
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Such PSM was then transferred to affect the cancer cells which have been cultured overnight. 
For both direct and indirect CAP treatment, the control group corresponded to the cancer cells 
grown in the new DMEM with a specific volume without the CAP treatment. Then, cancer cells 
were cultured in the incubator under the standard culture conditions for 3 hr. Subsequently, the 
thin layer of DMEM around the cancer cells in each well was removed. 100 μL of new untreated 
DMEM was added in the well and cultured cancer cells for 3 days before the final cell viability 
assay. In this study, the treatment just using helium rather than CAP was also performed. The 
protocols were the same as the description above except that no discharge was used. In another 
case, the DMEM covering the cells needed to be replaced immediately after the CAP treatment. 
After removing the CAP-treated DMEM, 100 μL of new untreated DMEM was added to culture 
cells for 3 days before the final cell viability assay.  
 
Cell viability assay. MTT (3-(4,5-Dimethyl-2-thiazol)-2,5-Diphenyl-2H-tetrazolium Bromide) 
assay was performed following the protocol provided by manufacturer (M2128, Sigma-Aldrich). 
The original experimental data about the cell viability was the absorbance at 570 nm measured 
by a H1 microplate reader (Hybrid Technology). The original absorbance at 570 nm was 
processed to be a relative cell viability through the division between the absorbance of the 
CAP-treated cancer cells and the absorbance of the cancer cells without the CAP treatment.  
 
Extracellular H2O2 assay. The H2O2 concentration in DMEM or PBS was measured by using 
Fluorimetric Hydrogen Peroxide Assay Kit (Sigma-Aldrich, MAK165-1KT) following the 
protocols provided by manufacturer (Sigma-Aldrich). The fluorescence was measured by a H1 
microplate reader (Hybrid Technology) at 540/590 nm. The final fluorescence of the 
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experimental group was obtained by deducting the measured fluorescence of the control group 
from the measured fluorescence of the experimental group. Based on the standard curve, the 
H2O2 concentration in DMEM or PBS was obtained. Because the recommended volume of the 
sample solution was 50 μL, when the volume of sample solution was less than 50 μL but larger 
than 10 μL, we just collected 10 μL of the sample solution and mixed it with 40 μL of the 
untreated DMEM to make a 50 μL of the diluted sample solution. The H2O2 concentration of 
such case was 5 times larger than the measured concentration.  
 
Measuring the H2O2 consumption speed by cancer cells. The protocols for different cancer 
cell lines are the same. Here, we just use PA-TU-8988T cells as an example. First, 100 μL of the 
PA-TU-8988T cells harvesting solution was seeded in a well on a 96-wells plate with a 
confluence of 6x104 cells/mL. 3 wells were seeded as 3 samples for one experiment. Cells were 
cultured in incubator for 6 hr under the standard conditions. Then, 1 mL of DMEM or PBS in a 
well on a 12-wells plate was treated by CAP for 1 min. After that, the medium which has been 
used to culture cells for 6 hr was removed. 120 μL of the CAP-treated DMEM or 
H2O2-containing DMEM (H2O2-DMEM) was transferred to culture PA-TU-8988T cells in one 
well on a 96-wells plate. 36.3 μM H2O2-DMEM was made by adding 9.8 M H2O2 standard 
solution (216763, Sigma-Aldrich) in DMEM. Since then until the third hour, 50 μL of the 
DMEM which has been used to culture cells was transferred to a well on a black clear bottom 
96-wells plate in triplicate every hour. Ultimately, the residual H2O2 concentration in DMEM 
was measured using fluorimetric hydrogen peroxide assay kit illustrated above.  
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Fig. 1. Only the direct CAP treatment can trigger the H2O2 production of specific cancer 
cell lines in vitro. (A) The H2O2 concentration in DMEM after the CAP treatment on just 
DMEM, on pancreatic adenocarcinoma cells (PA-TU-8988T) immerged in DMEM, on breast 
adenocarcinoma cells (MDA-MB-231) immerged in DMEM, as well as on glioblastoma cells 
(U87MG) immerged in DMEM. (B) The cells-based H2O2 concentration. The data is calculated 
based on the following formula. Cells-based H2O2 concentration = H2O2 concentration in the 
DMEM which has been used to immerse cancer cells during the CAP treatment – H2O2 
concentration in the CAP-treated DMEM. The H2O2 concentration corresponds to the mean of 
each bar shown in 1A. (C) The indirect CAP treatment will not stimulate cancer cells to generate 
H2O2. All H2O2 concentration was measured immediately (about 1 min) after the treatment. 
Results are presented as the mean ± s.d. of three independently repeated experiments. Student’s 
t-test was performed between the data based on cells immersed in specific volume of DMEM 
and the data just based on the DMEM with the same volume. The significance is indicated as * p 
<0.05. 
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Fig. 2. H2O2 evolution in the DMEM surrounding cancer cells after the direct CAP 
treatment. (a) Cancer cells immersed in 20 μL of DMEM. (b) Cancer cells immersed in 100 μL 
of DMEM. CAP was used to treat DMEM or cancer cells (MDA-MB-231 cells, PA-TU-8988T 
cells, and U87MG cells) immersed in DMEM. In each experiment, the 1 min of CAP treatment 
was performed on the cells immersed in 20 μL or 100 μL of DMEM. The H2O2 concentration 
was measured very minute after the CAP treatment until the tenth minute. Cancer cells in 
96-wells plate were cultured overnight before the CAP treatment. The cell confluence was 3 x 
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104 cells/mL. Results are presented as the mean ± s.d. of three independently repeated 
experiments.  
 
 
Fig. 3. The cell confluence and the output voltage affect the cell-based H2O2 generation. (a) 
A relative small confluence can achieve the maximum cell-based H2O2 generation. (b) High 
output AV voltage significantly weakens the cell-based H2O2 generation. In each experiment, a 1 
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min of CAP treatment was performed on the cancer cells immersed in 100 μL of DMEM. The 
H2O2 concentration was measured immediately (about 1 min) after the treatment. Cancer cells 
were cultured overnight before the treatment. The cell confluence for (b) was 3 x 104 cells/mL. 
Results are presented as the mean ± s.d. of three independently repeated experiments. Student’s 
t-test was performed and the significance is indicated as * p <0.05.  
 
 
 
Fig. 4. Under the same experimental conditions, the anti-cancer capacity of the direct CAP 
treatment is significantly stronger than the indirect CAP treatment. For the indirect CAP 
treatment, the CAP-stimulated DMEM was used to affect the growth of cancer cells. Comparison 
between the direct CAP treatment and the indirect treatment is performed on (a) MDA-MB-231 
cells and (b) PA-TU-8988T cells. Pre-treating cancer cells with 6 mM NAC an intracellular 
scavenger for 3 hr or immediately (about 1 min) renewing the DMEM after the direct CAP 
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treatment can effectively weakens the anti-cancer capacity of the direct CAP treatment on (c) 
MDA-MB-231 cells and (d) PA-TU-8988T cells. Results are presented as the mean ± s.d. of 
three independently repeated experiments. Student’s t-test was performed between the results 
from the direct CAP treatment and the results from the indirect CAP treatment. The significance 
is indicated as * p <0.05. 
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Fig. S1. Cancer cells quickly consume the H2O2 in CAP-stimulated DMEM (CAP’s medium) 
and in H2O2-containing DMEM (H2O2-DMEM) in hours. Consuming H2O2 is a basic feature 
of cancer cells exposed to H2O2. 1 hr, 2 hr, and 3 hr represent the time length that two cell lines 
cultured in CAP’s DMEM or in H2O2-DMEM. The initial H2O2 concentration in CAP’s medium 
and H2O2- DMEM is the same and is not shown at here. K represent 1 x 10
3. Results are 
presented as the mean ± s.d. of two independently repeated experiments in triplicate.  
 
 
 
 
Fig. S2. The effect of helium flow on the cell viability of cancer cells. (a) PA-TU-8988T cells. 
(b) MDA-MB-231 cells. Results are presented as the mean ± s.d. of three independently repeated 
experiments.  
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Fig. S3. Schematic illustration of the protocols for the CAP treatment. (a) Direct CAP 
treatment. (b) Indirect CAP treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
